Pennington, B, Alshreef, A, Flight, L, Metry, A, Poku, E, Hykin, P, Sivaprasad, S, Prevost, A T, Vasconcelos, J C, Murphy, C, Kelly, J, Yang, Y, Lotery, A, Williams, M & Brazier, J 2021, ' Correction to : Cost Effectiveness of Ranibizumab vs Aflibercept vs Bevacizumab for the Treatment of Macular Oedema Due to Central Retinal Vein Occlusion: The LEAVO Study (PharmacoEconomics, (2021), 10.1007/s40273-021-01026-5) ', PharmacoEconomics, vol. 39, 1099 . https://doi.org/10.1007/s40273-021-01057-y